Emergent BioSolutions Gestion
Gestion contrôle des critères 1/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Joe Papa
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 1.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 3.3yrs |
Mises à jour récentes de la gestion
Recent updates
Emergent BioSolutions Inc. (NYSE:EBS) Shares Fly 32% But Investors Aren't Buying For Growth
Nov 09
Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic
Nov 08Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way?
Oct 28Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario
Oct 04Little Excitement Around Emergent BioSolutions Inc.'s (NYSE:EBS) Revenues As Shares Take 27% Pounding
Sep 16Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
Aug 18Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 02Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
Jul 15Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09PDG
Joe Papa (68 yo)
less than a year
Titularisation
Mr. Joseph C. Papa, Jr. also known as Joe, is Independent Non-Executive Director of Milestone Pharmaceuticals Inc. since September 3, 2024. Mr. Papa serves as Executive Advisor at Water Street Healthcare P...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive VP | 6.7yrs | US$2.18m | 0.32% $ 1.6m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.6yrs | US$1.68m | 0.30% $ 1.5m | |
| Senior Vice President of Products Business | 1.8yrs | US$1.06m | 0.045% $ 228.7k | |
| CEO, President & Director | less than a year | pas de données | pas de données | |
| Senior VP | less than a year | pas de données | 0.013% $ 64.0k | |
| Senior VP & Chief Human Resource Officer | 1.7yrs | pas de données | pas de données | |
| Senior VP | 1.7yrs | pas de données | pas de données | |
| Senior Vice President of Manufacturing & Bioservices | no data | pas de données | 0.088% $ 446.3k |
1.7yrs
Durée moyenne de l'emploi
58.5yo
Âge moyen
Gestion expérimentée: L'équipe de direction de EBS n'est pas considérée comme expérimentée (ancienneté moyenne 1.7 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, President & Director | less than a year | pas de données | pas de données | |
| Independent Director | 18.4yrs | US$400.23k | 0.099% $ 502.1k | |
| Independent Director | 19.8yrs | US$394.73k | 0.037% $ 186.5k | |
| Independent Director | 1.1yrs | US$397.50k | 0.027% $ 136.9k | |
| Independent Director | 2.6yrs | US$396.99k | 0.011% $ 53.9k | |
| Independent Director | 4.1yrs | US$405.98k | 0.068% $ 344.6k | |
| Independent Non-Executive Chairman | 20.3yrs | US$535.98k | 0.070% $ 357.7k | |
| Independent Director | 8.1yrs | US$413.48k | 0.068% $ 348.3k | |
| Independent Director | 1.1yrs | US$398.75k | pas de données | |
| Independent Director | 2.3yrs | US$382.23k | 0.0073% $ 37.1k |
3.3yrs
Durée moyenne de l'emploi
65yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de EBS sont considérés comme expérimentés (ancienneté moyenne 3.3 ans).